
Non-clear cell renal cell carcinoma (nccRCC) is a heterogeneous category comprising approximately 25% of epithelial renal tumors. Unlike their far more common clear cell counterpart, many nccRCC subtypes are rare, poorly understood, and often aggressive in nature. Treatment options are very limited and generally have been unsuccessfully extrapolated from ccRCC trials. Numerous subtypes also seem to emerge in the context of inherited conditions or syndromes affecting younger individuals. In recent years, the World Health Organization classification of renal tumors has been frequently updated with the recognition of novel entities beyond ccRCC. The recommendations currently demonstrate a shift from morphology-based to molecularly based classification. Thus, aberrations in genes such as TFE3, TFEB, FH, SDH, SMARCB1, ELOC, and ALK define separate entities that cannot be distinguished on the basis of microscopic appearance alone. This review aims to deconstruct the general and nondescriptive term of nccRCC to provide a comprehensive presentation of specific subtypes, highlighting their epidemiologic associations and distinctive biological and clinicopathologic features. Delineating these complexities reveals areas that warrant improvement, which will translate into optimal diagnosis, treatment, and overall patient care.
Humans, Carcinoma, Renal Cell
Humans, Carcinoma, Renal Cell
| citations The total number of citations received by all articles of the researcher of interest. | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
